These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16862721)

  • 21. Fresh dispute about MMR 'fraud'.
    Reich ES
    Nature; 2011 Nov; 479(7372):157-8. PubMed ID: 22071737
    [No Abstract]   [Full Text] [Related]  

  • 22. MMR vaccine and autism.
    Griffin JP
    Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):99-100. PubMed ID: 10967744
    [No Abstract]   [Full Text] [Related]  

  • 23. Disclosure of conflicts of interest in biomedical publications.
    Miller DR
    Can J Anaesth; 2008 May; 55(5):265-7, 267-9. PubMed ID: 18451113
    [No Abstract]   [Full Text] [Related]  

  • 24. Mercury rising.
    Hughes V
    Nat Med; 2007 Aug; 13(8):896-7. PubMed ID: 17679997
    [No Abstract]   [Full Text] [Related]  

  • 25. The natural history of autistic syndrome in British children exposed to MMR.
    Spitzer WO; Aitken KJ; Dell'Aniello S; Davis MW
    Adverse Drug React Toxicol Rev; 2001 Aug; 20(3):160-3. PubMed ID: 11668865
    [No Abstract]   [Full Text] [Related]  

  • 26. MMR and autism: moving from controversy toward consensus.
    Coffin SE
    Expert Rev Vaccines; 2002 Aug; 1(2):145-50. PubMed ID: 12901553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why did the Lancet take so long?
    Greenhalgh T
    BMJ; 2010 Feb; 340():c644. PubMed ID: 20124363
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathology reports solve "new bowel disease" riddle.
    Deer B
    BMJ; 2011 Nov; 343():d6823. PubMed ID: 22077090
    [No Abstract]   [Full Text] [Related]  

  • 29. Wakefield tells GMC he was motivated by concern for autistic children.
    Dyer O
    BMJ; 2008 Apr; 336(7647):738. PubMed ID: 18390510
    [No Abstract]   [Full Text] [Related]  

  • 30. Lancet retracts Wakefield's MMR paper.
    Dyer C
    BMJ; 2010 Feb; 340():c696. PubMed ID: 20124366
    [No Abstract]   [Full Text] [Related]  

  • 31. New evidence reaffirms the safety of the MMR vaccine.
    Glasper EA
    Br J Nurs; 2002 Jun 27-Jul 10; 11(12):794. PubMed ID: 12131827
    [No Abstract]   [Full Text] [Related]  

  • 32. MMR and autism: the debate continues.
    Thrower D
    Lancet; 2004 Feb; 363(9408):567-8; author reply 568-9. PubMed ID: 14975622
    [No Abstract]   [Full Text] [Related]  

  • 33. A response to 'measles, mumps, rubella vaccine: through a glass, darkly' by Drs AJ Wakefield and SM Montgomery and published reviewers' comments.
    Arlett P; Bryan P; Evans S
    Adverse Drug React Toxicol Rev; 2001 Mar; 20(1):37-45. PubMed ID: 11395937
    [No Abstract]   [Full Text] [Related]  

  • 34. Informed choice and balance are victims of the MMR-autism saga.
    Jefferson T
    Lancet Infect Dis; 2004 Mar; 4(3):135-6. PubMed ID: 14998496
    [No Abstract]   [Full Text] [Related]  

  • 35. Setting the record straight: vaccines, autism, and the Lancet.
    Ratzan SC
    J Health Commun; 2010 Apr; 15(3):237-9. PubMed ID: 20432106
    [No Abstract]   [Full Text] [Related]  

  • 36. UK autism fracas fuels calls for peer review reform.
    Spinney L
    Nat Med; 2004 Apr; 10(4):321. PubMed ID: 15057212
    [No Abstract]   [Full Text] [Related]  

  • 37. Editor in the eye of a storm.
    Lyall J
    BMJ; 2004 Feb; 328(7438):528. PubMed ID: 15164721
    [No Abstract]   [Full Text] [Related]  

  • 38. Medical editors to take tougher line.
    Coghlan A
    New Sci; 2004 Mar 6-12; 181(2437):11. PubMed ID: 15139349
    [No Abstract]   [Full Text] [Related]  

  • 39. Myth misgiving rationale.
    Crouch D
    Nurs Times; 2001 Mar 29-Apr 4; 97(13):22-4. PubMed ID: 11954267
    [No Abstract]   [Full Text] [Related]  

  • 40. Separating inflammation from speculation in autism.
    Murch S
    Lancet; 2003 Nov; 362(9394):1498-9. PubMed ID: 14602448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.